Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Non-founder BRCA1 mutations in Russian breast cancer patients.

Cancer letters - 8 Dec 2010

Iyevleva Aglaya G, Suspitsin Evgeny N, Kroeze Karin, Gorodnova Tatiana V, Sokolenko Anna P, Buslov Konstantin G, Voskresenskiy Dmitry A, Togo Alexandr V, Kovalenko Sergey P, Stoep Nienke van der, Devilee Peter, Imyanitov Evgeny N

Abstract excerpt

A few founder BRCA1 mutations (5382insC, 4154delA, 185delAG) account for up to 15% of high-risk (young-onset or familial or bilateral) breast cancer (BC) cases in Russia. The impact of non-founder BRCA1 mutations in this country is less studied; in particular, there are no reports analyzing gross...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to BRCA1 Protein
Share to DNA, Neoplasm
Share to Family Health

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Founder Effect

Share to Gene Deletion

Share to Nucleic Acid Amplification Techniques

Share to Ovarian Neoplasms

Share to Russia

Source

Identifiers

PMID: 20727672
DOI: 10.1016/j.canlet.2010.07.013

Genes

BRCA1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-20727672-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Non-founder BRCA1 mutations in Russian breast cancer patients.PMID 20727672Read ↗

Founder mutations in early-onset, familial and bilateral breast cancer patients from Russia.Semantic proximity Read ↗

Frequency and spectrum of founder and non-founder BRCA1 and BRCA2 mutations in a large series of Russian breast cancer and ovarian cancer patients.Semantic proximity Read ↗

High prevalence and breast cancer predisposing role of the BLM c.1642 C>T (Q548X) mutation in Russia.Semantic proximity Read ↗

High frequency of BRCA1, but not CHEK2 or NBS1 (NBN), founder mutations in Russian ovarian cancer patientsSemantic proximity Read ↗

The Molecular Analysis of BRCA1 Mutations in the First Slovak Patients with Suspected Familial Breast CancerSemantic proximity Read ↗

High frequency of BRCA1 5382insC mutation in Russian breast cancer patients.Semantic proximity Read ↗

Analysis of BRCA1 large genomic rearrangements to identify individuals at risk of breast cancerSemantic proximity Read ↗

[Prevalence of widespread BRCA1 gene mutations in patients with familial breast cancer from St. Petersburg].Semantic proximity Read ↗

Current guidelines for BRCA testing of breast cancer patients are insufficient to detect all mutation carriers.Semantic proximity Read ↗

Identification of germline BRCA1 mutations among breast cancer families in Northeastern Iran.Semantic proximity Read ↗

BRCA1 and BRCA2 germline mutations screening in Algerian breast/ovarian cancer families.Semantic proximity Read ↗

Identification of a founder BRCA1 mutation in the Moroccan population.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.